Siemens Medical Systems’ ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the unit’s applications to include surgical and intensive care uses. The company unveiled five new transducers for its
Siemens Medical Systems ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the units applications to include surgical and intensive care uses. The company unveiled five new transducers for its Sonoline Sienna 2.0 unit for surgery and intensive care environments. The transducers will allow physicians to use Sonoline Sienna for traditional open surgeries, ultrasound-guided biopsies and aspiration procedures, and laparoscopies.
The four interventional transducers7.5L50, 7.5L50-Q, Lb5-2 Biopsy Linear Array, and LAP 8-4are smaller and lighter and carry higher resolution than other transducers, and were developed for such indications as vascular imaging. Issaquah, WA-based Siemens developed its fifth transducer, C8-5, for neonatal intensive care.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.